ethambutol has been researched along with Cranial Nerve II Diseases in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (11.63) | 18.7374 |
1990's | 5 (5.81) | 18.2507 |
2000's | 25 (29.07) | 29.6817 |
2010's | 25 (29.07) | 24.3611 |
2020's | 21 (24.42) | 2.80 |
Authors | Studies |
---|---|
Gandhi, R; Garg, R; Kalaiselvan, V; Karna, S; Lodha, R; Menon, V; Mohan, A; Phuljhele, S; Prakash, A; Saxena, R; Singh, D | 2 |
Gómez-Calleja, V; Ly-Yang, F; Pérez-García, P; Santos-Bueso, E | 1 |
Fujiwara, K; Furuuchi, K; Hanada, K; Kaburaki, S; Kurashima, A; Morimoto, K; Ohta, K; Shiraishi, Y; Tanaka, Y; Uesugi, F; Watanabe, F; Yoshiyama, T | 1 |
Panigrahi, PK | 1 |
Fus, M; Kyncl, M; Lestak, J | 1 |
Aalok, SP; Banerjee, M; Gk, R; Mandal, S; Saxena, A; Saxena, R; Sen, S | 1 |
Bhargava, A; Das, AV; Kammari, P; Kurada, J; Sahoo, NK; Sheth, J; Shukla, S; Tyagi, M | 1 |
Gella, V; Ismail, M; Rao, R; Sabhapandit, S; Shireesha, A; Talukdar, R; Thankachan, L | 1 |
Abdallah, E; Berraho, HA; Hasnaoui, I; Hassina, S; Krichene, MA; Mrad, K; Serghini, L | 1 |
Chang, YF; Chen, SW; Cheng, HC; Fann, MJ; Liou, RH; Wang, AG; Wong, YH; Wu, PC | 1 |
Balakrishnan, HK; Jayasri, KN; Kowsalya, A; Sajja, S; Shanmugam, MK | 1 |
Dhiman, R; Guleria, R; Mandal, S; Mohan, A; Padhy, SK; Phuljhele, S; Saxena, R; Sharma, P | 1 |
Addy, LK; Harrison, WW | 1 |
Bao, Z; Ge, W; Li, Q; Sha, X; Sheng, W; Su, L; Wu, S; Xu, Q; Zhu, L | 1 |
Hwang, JM; Yang, HK; Yoo, YJ | 1 |
Aihara, K; Arisawa, A; Fujiki, T; Kusabiraki, R; Matsumoto, T; Mishima, M; Noda, A; Tanaka, A; Yamamoto, N; Yamaoka, S | 1 |
Gandhi, R; Garg, R; Karna, S; Lodha, R; Menon, V; Mohan, A; Phuljhele, S; Prakash, A; Saxena, R; Singh, D | 1 |
Ge, W; Sheng, WY; Su, LY; Wu, SQ; Zhu, LW | 1 |
Biswas, S; Murumkar, VS; Prabhuraj, AR; Saini, JS | 1 |
Falardeau, J; Henkle, E; Winthrop, KL; Yang, S | 1 |
Berry, S; Chamberlain, PD; Lee, AG; Sadaka, A | 1 |
Kung, NH; Lu, PG; Van Stavern, GP | 1 |
Choi, JH; Lee, JY; Oh, SY; Park, KA | 1 |
Han, J; Lee, JY; Oh, SY; Park, KA; Seo, JG | 1 |
Boisvert, CJ; Gallagher, SP; Kenney, MC; Lee, DH; Yu, JJ | 1 |
Icel, E; Karakurt, Y; Keskin Cimen, F; Kurt, N; Süleyman, H; Tasli, G; Ucak, T | 1 |
Agarwal, R; Jain, VK; Kanaujia, V; Mishra, P; Sharma, K; Sharma, RK | 1 |
Handor, H; Ibrahimy, W | 1 |
Geyer, HL; Herskovitz, S; Schaumburg, HH; Slamovits, TL | 1 |
Chen, SC; Lin, MC; Sheu, SJ | 1 |
Byun, MK; Han, J; Han, SH; Han, SY; Lee, J; Lee, JB | 1 |
Libershteyn, Y | 1 |
Hwang, JM; Lee, CT; Lee, JH; Park, JS; Park, MJ; Yang, HK | 1 |
Bouffard, MA; Nathavitharana, RR; Torun, N; Yassa, DS | 1 |
Si, S; Song, W | 1 |
Aghdam, KA; Grzybowski, A; Saari, JM; Wasinska-Borowiec, W | 1 |
Alffenaar, JW; Hasenbosch, RE; Koopmans, SA; Kosterink, JG; van Altena, R; van der Werf, TS | 1 |
Martini, BC | 1 |
Fahimi, A; Fink, W; Kim, JK; Nazemi, PP; Nguyen, D; Sadun, AA | 1 |
Choung, HK; Kim, JH; Kim, SJ; Lee, EJ; Yu, YS | 1 |
Sadun, AA; Wang, MY | 1 |
Jain, D; Menon, V; Saxena, R; Sood, R | 1 |
Amati-Bonneau, P; Bonneau, D; Cassereau, J; Chevrollier, A; Desquiret, V; Gueguen, N; Guillet, V; Letournel, F; Procaccio, V; Reynier, P; Richard, L; Verny, C | 1 |
Hwang, JM; Kim, YK | 1 |
Chatziralli, IP; Keryttopoulos, P; Papadopoulou, D; Papazisis, L; Sergentanis, TN | 1 |
Lam, BL; Masvidal, D; Parrish, RK | 1 |
Al-Obailan, M; Arnold, AC; Kho, RC | 1 |
Lim, SA; Lun, KW | 1 |
Wang, W; Xhang, XL; Yang, H | 1 |
Iwata, N; Kimotsuki, T; Kinoshita, J; Maejima, T; Yasuda, M | 1 |
Chen, HY; Chen, PC; Lai, SW; Muo, CH; Wang, IJ | 1 |
Arı, Ş; Çaça, İ; Çınar, Y; Evliyaoğlu, O; Gökalp, O; Kaya, S; Kürşat Cingü, A; Murat, M; Şahin, A; Türkcü, FM; Türkcü, G; Yüksel, H | 1 |
Calvert, PC; Cornblath, WT | 1 |
Hwang, JM; Kim, J; Park, SS | 1 |
Chuenkongkaew, W; Samsen, P; Thanasombatsakul, N | 1 |
Guépratte, N; Lebuisson, DA | 1 |
CARR, RE; HENKIND, P | 1 |
Kosmorsky, GS; Lee, MS; Melamud, A | 1 |
Castro, A; Frisch, IB; Krastel, H; Kunze, AK; Meinck, HM | 1 |
Herchline, TE | 1 |
Agarwal, M; Sadun, AA; Zoumalan, CI | 1 |
Bhatia, A; Goyal, JL; Singh, NP | 1 |
Chan, WM; Lai, TY; Lam, DS; Lim, E | 1 |
Lim, SA | 1 |
Fraunfelder, FW; Sadun, AA; Wood, T | 1 |
Chai, SJ; Foroozan, R | 1 |
Sadun, AA; Zoumalan, CI | 1 |
Cordonnier, M | 1 |
Fraunfelder, FW; Lloyd, MJ | 1 |
Casu, L; Guerra, R | 1 |
Desbordes, JM; Hamard, H | 1 |
Chaglasian, MA; Russo, PA | 1 |
Khosla, PK; Kumar, A; Sandramouli, S; Tewari, HK; Verma, L | 1 |
Jou, JR; Liaw, SL; Woung, LC | 1 |
Lee, YH; Tsai, RK | 1 |
Bosković, I; Bujanić-Cuculić, S; Filipović, T | 1 |
De Deyn, PP; Verslegers, W | 1 |
De Marinis, M | 1 |
Karmon, G; Levi, J; Savir, H; Zevin, D | 1 |
Lessell, S | 1 |
Brontë-Stewart, J; Foulds, WS; Pettigrew, AR | 1 |
Bragliani, G; De Palma, P; Fiorenza, M; Franco, F; Marescotti, A; Michetti, L; Pirazzoli, G | 1 |
Adachi-Usami, E; Kakisu, Y; Mizota, A | 1 |
Carmichael, TR; Salmon, JF; Welsh, NH | 1 |
Jaeger, W; Koelb, R; Krastel, H; Seiberth, V | 1 |
15 review(s) available for ethambutol and Cranial Nerve II Diseases
Article | Year |
---|---|
Ethambutol-induced optic neuropathy: Functional and structural changes in the retina and optic nerve.
Topics: Antitubercular Agents; Ethambutol; Evoked Potentials, Visual; Humans; Optic Nerve; Optic Nerve Diseases; Retina; Retinal Ganglion Cells; Tomography, Optical Coherence | 2022 |
Ethambutol optic neuropathy in the extended anti-tubercular therapy regime: A systematic review.
Topics: Checklist; Ethambutol; Evoked Potentials, Visual; Humans; Optic Nerve; Optic Nerve Diseases; Rare Diseases | 2023 |
Drastically Progressive Ethambutol-induced Optic Neuropathy after Withdrawal of Ethambutol: A Case Report and Literature Review.
Topics: Aged, 80 and over; Antitubercular Agents; Ethambutol; Eye; Humans; Male; Optic Nerve Diseases | 2021 |
Ethambutol optic neuropathy.
Topics: Antitubercular Agents; Ethambutol; Evoked Potentials, Visual; Humans; Nerve Fibers; Optic Nerve Diseases; Prevalence; Retinal Ganglion Cells; Tomography, Optical Coherence; Visual Field Tests | 2017 |
Mitochondrial Impairment in Antibiotic Induced Toxic Optic Neuropathies.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Ethambutol; Humans; Linezolid; Mitochondrial Diseases; Nerve Fibers; Optic Nerve Diseases; Vision Disorders; Visual Acuity | 2018 |
The rare ethambutol-induced optic neuropathy: A case-report and literature review.
Topics: Aged; Antitubercular Agents; Ethambutol; Humans; Male; Optic Nerve Diseases; Prognosis | 2017 |
An Updated Review on the Most Common Agents Causing Toxic Optic Neuropathies.
Topics: Amiodarone; Erythropoietin; Ethambutol; Humans; Linezolid; Methanol; Optic Nerve Diseases; Phosphodiesterase 5 Inhibitors | 2017 |
[Adverse effect optic neuropathy].
Topics: Acetamides; Amiodarone; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Linezolid; Optic Nerve Diseases; Oxazolidinones | 2008 |
[Present status of ethambutol-induced optic neuropathy].
Topics: Antitubercular Agents; Ethambutol; Humans; Optic Nerve Diseases | 2012 |
[Diagnosis of a toxic and/or deficiency optical neuropathy].
Topics: Deficiency Diseases; Diagnosis, Differential; Diagnostic Techniques, Ophthalmological; Ethambutol; Ethanol; Humans; Isoniazid; Nicotiana; Optic Nerve Diseases | 2003 |
Ocular ethambutol toxicity.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Optic Nerve Diseases; Tuberculosis | 2003 |
Update on ethambutol optic neuropathy.
Topics: Antitubercular Agents; Ethambutol; Humans; Optic Nerve Diseases; Product Surveillance, Postmarketing | 2006 |
[Toxicity of recent and less recent drugs on the optic nerve. Does Viagra cause blindness?].
Topics: Acetamides; Amiodarone; Blindness; Ethambutol; Humans; Immunosuppressive Agents; Interferon-alpha; Linezolid; Optic Nerve; Optic Nerve Diseases; Oxazolidinones; Phosphodiesterase Inhibitors; Tamoxifen; Tumor Necrosis Factor-alpha | 2007 |
Drug-induced optic neuropathies.
Topics: Acetamides; Adverse Drug Reaction Reporting Systems; Amiodarone; Anti-Arrhythmia Agents; Anti-Infective Agents; Antitubercular Agents; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Linezolid; Optic Nerve Diseases; Oxazolidinones; Phosphodiesterase Inhibitors | 2007 |
[Iatrogenic pathology of the optic nerve].
Topics: Adrenal Cortex Hormones; Antiprotozoal Agents; Chloramphenicol; Contraceptives, Oral; Ethambutol; Female; Humans; Iatrogenic Disease; Isoniazid; Monoamine Oxidase Inhibitors; Optic Nerve Diseases; Phenytoin; Quinine; Radiotherapy; Surgical Procedures, Operative; Vitamins | 1982 |
1 trial(s) available for ethambutol and Cranial Nerve II Diseases
Article | Year |
---|---|
Evaluation of visual functions in patients on ethambutol therapy for tuberculosis: a prospective study.
Topics: Adult; Antitubercular Agents; Ethambutol; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Optic Nerve Diseases; Prospective Studies; Tuberculosis; Visual Acuity | 2003 |
70 other study(ies) available for ethambutol and Cranial Nerve II Diseases
Article | Year |
---|---|
Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy.
Topics: Antitubercular Agents; Consensus; Ethambutol; Humans; Optic Nerve Diseases; Primary Prevention | 2021 |
Optic neuropathy by ethambutol in a patient with multiple sclerosis.
Topics: Antitubercular Agents; Ethambutol; Humans; Multiple Sclerosis; Optic Nerve; Optic Nerve Diseases | 2022 |
Low-dosage ethambutol, less than 12.5 mg/kg/day, does not worsen the clinical outcomes of pulmonary Mycobacterium avium and Mycobacterium intracellulare disease: a retrospective cohort study.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Optic Nerve Diseases; Retrospective Studies; Rifampin; Treatment Outcome | 2022 |
Comment on: Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis, and management of ethambutol-induced optic neuropathy.
Topics: Consensus; Ethambutol; Humans; Optic Nerve; Optic Nerve Diseases; Primary Prevention | 2022 |
Response to comment on: Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis, and management of ethambutol-induced optic neuropathy.
Topics: Consensus; Ethambutol; Humans; Optic Nerve; Optic Nerve Diseases; Primary Prevention | 2022 |
Ethambutol-induced optic neuropathy.
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Optic Nerve; Optic Nerve Diseases; Tomography, Optical Coherence; Tuberculosis | 2023 |
From Scylla to Charybdis: Fixed drug combinations for tuberculosis and increased ethambutol-induced optic neuropathy in India.
Topics: Adult; Antitubercular Agents; Drug Combinations; Ethambutol; Female; Humans; India; Male; Middle Aged; Optic Nerve Diseases; Tuberculosis | 2022 |
[Ethambutol-induced toxic optic neuropathy during treatment of tuberculosis meningitis in a child].
Topics: Antitubercular Agents; Child; Ethambutol; Humans; Optic Nerve Diseases; Toxic Optic Neuropathy; Tuberculosis, Meningeal | 2023 |
The efficient induction of human retinal ganglion-like cells provides a platform for studying optic neuropathies.
Topics: Apoptosis; Ethambutol; Humans; Induced Pluripotent Stem Cells; Optic Nerve Diseases; Reactive Oxygen Species; Retinal Ganglion Cells; SOXC Transcription Factors | 2023 |
Ethambutol induced toxic optic neuropathy - A retrospective study in a tertiary eye care centre in Southern India.
Topics: Ethambutol; Humans; India; Optic Nerve Diseases; Retrospective Studies; Toxic Optic Neuropathy | 2022 |
Prospective study to evaluate incidence and indicators for early detection of ethambutol toxicity.
Topics: Adult; Aged; Antitubercular Agents; Color Vision; Contrast Sensitivity; Ethambutol; Evoked Potentials, Visual; Female; Humans; Incidence; Male; Middle Aged; Nerve Fibers; Optic Nerve; Optic Nerve Diseases; Prospective Studies; Retinal Ganglion Cells; Tomography, Optical Coherence; Visual Acuity; Visual Fields; Young Adult | 2021 |
Case Report: Long-term Structural and Functional Effects of Ethambutol Optic Neuropathy.
Topics: Antitubercular Agents; Electroretinography; Ethambutol; Evoked Potentials, Visual; Follow-Up Studies; Humans; Male; Middle Aged; Nerve Fibers; Optic Nerve Diseases; Retinal Ganglion Cells; Scotoma; Tomography, Optical Coherence; Visual Acuity; Visual Fields | 2020 |
Characterisation of macular superficial vessel density alteration in preclinical ethambutol-induced optic neuropathy using optical coherence tomography angiography.
Topics: Angiography; Ethambutol; Humans; Intraocular Pressure; Nerve Fibers; Optic Nerve Diseases; Retinal Ganglion Cells; Retrospective Studies; Tomography, Optical Coherence; Tuberculosis | 2022 |
Pupillary light reflex in ethambutol-induced optic neuropathy.
Topics: Antitubercular Agents; Case-Control Studies; Ethambutol; Female; Humans; Light; Male; Middle Aged; Optic Nerve Diseases; Pupil; Visual Fields | 2020 |
Ethambutol Optic Neuropathy: Vigilance and Screening, the Keys to Prevent Blindness with the Revised Anti-tuberculous Therapy Regimen.
Topics: Antitubercular Agents; Blindness; Ethambutol; Humans; India; Optic Nerve Diseases; Tuberculosis | 2021 |
Analysis of structural injury patterns in peripapillary retinal nerve fibre layer and retinal ganglion cell layer in ethambutol-induced optic neuropathy.
Topics: Ethambutol; Humans; Nerve Fibers; Optic Nerve Diseases; Retina; Retinal Ganglion Cells; Tomography, Optical Coherence | 2021 |
"Neuroimaging in ethambutol induced optic neuropathy: MRI in time can save the vision".
Topics: Antitubercular Agents; Ethambutol; Evoked Potentials, Visual; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Optic Nerve Diseases; Recovery of Function; Tuberculosis, Osteoarticular; Vision Disorders; Withholding Treatment | 2021 |
Ethambutol-induced optic neuropathy in nontuberculous mycobacterial disease.
Topics: Antitubercular Agents; Ethambutol; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Optic Nerve Diseases | 2021 |
Ethambutol optic neuropathy associated with enhancement at the optic chiasm.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Humans; Magnetic Resonance Imaging; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Optic Chiasm; Optic Nerve Diseases; Visual Field Tests; Visual Fields | 2017 |
Ganglion Cell Layer and Inner Plexiform Layer as Predictors of Vision Recovery in Ethambutol-Induced Optic Neuropathy: A Longitudinal OCT Analysis.
Topics: Adult; Aged; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nerve Fibers; Optic Nerve; Optic Nerve Diseases; Recovery of Function; Retinal Ganglion Cells; Retrospective Studies; Tomography, Optical Coherence; Vision, Ocular | 2018 |
Diagnostic value of ganglion cell-inner plexiform layer for early detection of ethambutol-induced optic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Early Diagnosis; Ethambutol; Female; Humans; Intraocular Pressure; Male; Middle Aged; Nerve Fibers; Optic Nerve Diseases; Retinal Ganglion Cells; ROC Curve; Sensitivity and Specificity; Tomography, Optical Coherence; Tuberculosis; Visual Field Tests; Visual Fields | 2019 |
The effects of lutein on optic nerve injury induced by ethambutol and isoniazid: an experimental study.
Topics: Animals; Ethambutol; Eye; Glutathione; Interleukin-1beta; Isoniazid; Lutein; Male; Malondialdehyde; Optic Nerve Diseases; Rats, Wistar; Tumor Necrosis Factor-alpha | 2019 |
Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological study.
Topics: Adolescent; Adult; Antitubercular Agents; Ethambutol; Evoked Potentials, Visual; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Middle Aged; Optic Nerve; Optic Nerve Diseases; Prospective Studies; Visual Acuity; Young Adult | 2019 |
[Bilateral optic neuropathy induced by antituberculous treatment in a patient with renal failure].
Topics: Adult; Antitubercular Agents; Ethambutol; Humans; Male; Optic Nerve Diseases; Renal Insufficiency | 2013 |
Optochiasmatic and peripheral neuropathy due to ethambutol overtreatment.
Topics: Aged; Antitubercular Agents; Blindness; Ethambutol; Humans; Male; Optic Chiasm; Optic Nerve Diseases; Peripheral Nervous System Diseases; Tuberculosis, Pulmonary | 2014 |
Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Ethambutol; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Optic Nerve Diseases; Prognosis; Taiwan; Vision, Ocular | 2015 |
Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy.
Topics: Adult; Aged; Antitubercular Agents; Color Vision; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nerve Fibers; Optic Nerve Diseases; Prospective Studies; Retinal Ganglion Cells; Tomography, Optical Coherence; Tuberculosis, Pulmonary; Visual Acuity; Visual Field Tests | 2015 |
Ethambutol/Linezolid Toxic Optic Neuropathy.
Topics: Aged; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Ethambutol; HIV Infections; Humans; Linezolid; Male; Mycobacterium avium-intracellulare Infection; Optic Nerve Diseases; Vision, Low; Visual Acuity; Visual Fields | 2016 |
Incidence of toxic optic neuropathy with low-dose ethambutol.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Incidence; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Optic Nerve Diseases; Republic of Korea; Retrospective Studies; Risk Factors; Time Factors; Tuberculosis; Vision, Ocular; Young Adult | 2016 |
Re-Treatment With Ethambutol After Toxic Optic Neuropathy.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Optic Nerve Diseases; Retinal Ganglion Cells; Retreatment | 2017 |
Ethambutol-induced optical neuropathy: risk of overdosing in obese subjects.
Topics: Adult; Aged; Antitubercular Agents; Body Weight; Drug Overdose; Ethambutol; Female; Humans; Male; Middle Aged; Obesity; Optic Nerve Diseases; Retrospective Studies | 2008 |
Characterizing ethambutol-induced optic neuropathy with a 3D computer-automated threshold Amsler grid test.
Topics: Aged; Antitubercular Agents; Automation; Diagnosis, Computer-Assisted; Ethambutol; Female; Humans; Imaging, Three-Dimensional; Optic Nerve Diseases; Scotoma; Sensory Thresholds; Visual Fields | 2008 |
Incidence and clinical features of ethambutol-induced optic neuropathy in Korea.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Dose-Response Relationship, Drug; Ethambutol; Female; Glomerular Filtration Rate; Humans; Incidence; Korea; Male; Metabolic Clearance Rate; Middle Aged; Neurologic Examination; Optic Disk; Optic Nerve; Optic Nerve Diseases; Recovery of Function; Retrospective Studies; Vision, Low | 2008 |
Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year.
Topics: Adenosine Triphosphate; Antitubercular Agents; Apoptosis; Blindness; Drug Dosage Calculations; Ethambutol; Glomerular Filtration Rate; Humans; Metabolic Clearance Rate; Mitochondria; Optic Nerve Diseases; Risk Factors; Wallerian Degeneration | 2008 |
Prospective evaluation of visual function for early detection of ethambutol toxicity.
Topics: Adolescent; Adult; Antitubercular Agents; Child; Contrast Sensitivity; Early Diagnosis; Ethambutol; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Optic Nerve Diseases; Prospective Studies; Tuberculosis, Pulmonary; Visual Acuity; Young Adult | 2009 |
Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity.
Topics: Antitubercular Agents; Cells, Cultured; Electron Transport Complex IV; Ethambutol; Fibroblasts; Genetic Predisposition to Disease; GTP Phosphohydrolases; Humans; Mitochondria; Mitochondrial Diseases; Mutation; Optic Nerve Diseases | 2010 |
Serial retinal nerve fiber layer changes in patients with toxic optic neuropathy associated with antituberculosis pharmacotherapy.
Topics: Aged; Antitubercular Agents; Color Vision Defects; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Nerve Fibers; Optic Nerve Diseases; Retinal Neurons; Time Factors; Tomography, Optical Coherence; Visual Acuity; Visual Fields | 2009 |
Disentangling renal function in the context of irreversible ethambutol optic neuropathy.
Topics: Aged, 80 and over; Antitubercular Agents; Diagnostic Techniques, Urological; Ethambutol; Female; Humans; Kidney; Optic Nerve Diseases; Renal Insufficiency; Risk Factors | 2010 |
Structural-functional dissociation in presumed ethambutol optic neuropathy.
Topics: Antitubercular Agents; Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Neurotoxins; Optic Nerve Diseases | 2010 |
Bitemporal visual field defects in ethambutol-induced optic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Hemianopsia; Humans; Male; Middle Aged; Optic Nerve Diseases; Vision Tests; Visual Field Tests | 2011 |
Structural-functional dissociation observed during recovery phase of optic neuropathies.
Topics: Antitubercular Agents; Ethambutol; Humans; Male; Optic Nerve Diseases | 2011 |
Retinal function and morphology in monkeys with ethambutol-induced optic neuropathy.
Topics: Administration, Oral; Animals; Antitubercular Agents; Dark Adaptation; Disease Models, Animal; Electroretinography; Ethambutol; Macaca fascicularis; Microglia; Necrosis; Nerve Fibers; Optic Nerve Diseases; Photic Stimulation; Retina; Retinal Ganglion Cells | 2012 |
Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan.
Topics: Adult; Aged; Antitubercular Agents; Ethambutol; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Optic Nerve Diseases; Population Surveillance; Retrospective Studies; Risk Factors; Taiwan; Tuberculosis; Young Adult | 2012 |
The protective effects of caffeic acid phenethyl ester in isoniazid and ethambutol-induced ocular toxicity of rats.
Topics: Animals; Caffeic Acids; Ethambutol; Isoniazid; Male; Malondialdehyde; Optic Nerve Diseases; Oxidative Stress; Phenylethyl Alcohol; Protective Agents; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal Ganglion Cells; Superoxide Dismutase | 2013 |
Best catch from NANOSNET.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Exercise; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Middle Aged; Nystagmus, Congenital; Ocular Motility Disorders; Optic Nerve; Optic Nerve Diseases; Prednisone | 2002 |
Leber's hereditary optic neuropathy mutations in ethambutol-induced optic neuropathy.
Topics: Adult; Antitubercular Agents; DNA Mutational Analysis; DNA, Mitochondrial; Ethambutol; Female; Humans; Male; Middle Aged; Mutation; Optic Atrophy, Hereditary, Leber; Optic Nerve Diseases; Polymerase Chain Reaction | 2003 |
Ethambutol and optic neuropathy.
Topics: Adult; Antitubercular Agents; Ethambutol; Female; Humans; Male; Middle Aged; Optic Nerve Diseases; Tuberculosis, Lymph Node; Tuberculosis, Pulmonary | 2003 |
Ocular manifestations of ethambutol, Toxic amblyopia after administration of an experimental antituberculous drug.
Topics: Amblyopia; Antitubercular Agents; Ethambutol; Eye; Humans; Medical Records; Neuritis; Optic Nerve; Optic Nerve Diseases; Optic Neuritis; Scotoma; Vision, Ocular | 1962 |
[Severe course and contingent risk factors in optic neuropathy and myelopathy after tuberculostatics].
Topics: Adult; Antitubercular Agents; Disease Progression; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Male; Optic Nerve Diseases; Photophobia; Pyrazinamide; Rifampin; Risk Factors; Risk Management; Spinal Cord Diseases; Treatment Outcome; Tuberculosis, Lymph Node | 2003 |
Ocular ethambutol toxicity.
Topics: Antitubercular Agents; Color Perception Tests; Ethambutol; Humans; Optic Nerve Diseases | 2004 |
Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.
Topics: Aged; Antitubercular Agents; Axons; Diagnostic Techniques, Ophthalmological; Ethambutol; Female; Humans; Male; Optic Nerve Diseases; Retinal Ganglion Cells; Tomography, Optical Coherence; Visual Acuity | 2005 |
Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy.
Topics: Antitubercular Agents; Electroretinography; Ethambutol; Humans; Male; Middle Aged; Optic Nerve Diseases; Retinal Diseases | 2005 |
Ethambutol-associated optic neuropathy.
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Hemianopsia; Humans; Male; Middle Aged; Optic Nerve Diseases; Tuberculosis | 2006 |
Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Color Vision Defects; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nerve Fibers; Optic Nerve Diseases; Retinal Ganglion Cells; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Visual Fields | 2007 |
Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy.
Topics: Aged; Antitubercular Agents; Ethambutol; Humans; Male; Nerve Fibers; Optic Nerve Diseases; Tomography, Optical Coherence; Visual Fields | 2007 |
Hydroxycobalamin for ethambutol-induced optic neuropathy.
Topics: Ethambutol; Humans; Hydroxocobalamin; Optic Nerve Diseases | 1981 |
Toxic optic neuropathy associated with ethambutol: implications for current therapy.
Topics: Blindness; Ethambutol; Humans; Isoniazid; Male; Middle Aged; Optic Nerve Diseases; Tuberculosis, Pulmonary; Visual Acuity | 1994 |
Ocular ethambutol toxicity: is it reversible?
Topics: Adolescent; Adult; Aged; Ethambutol; Evoked Potentials, Visual; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Male; Middle Aged; Monitoring, Physiologic; Optic Nerve Diseases; Prognosis; Tuberculosis, Pulmonary; Vision Disorders; Visual Acuity | 1993 |
Visual function in recovered ethambutol optic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Color Perception; Contrast Sensitivity; Ethambutol; Evoked Potentials, Visual; Female; Flicker Fusion; Follow-Up Studies; Humans; Male; Middle Aged; Optic Nerve Diseases; Tuberculosis, Pulmonary; Visual Acuity; Visual Field Tests; Visual Fields | 1995 |
Reversibility of ethambutol optic neuropathy.
Topics: Adult; Aged; Antitubercular Agents; Ethambutol; Female; Humans; Male; Middle Aged; Optic Nerve Diseases | 1997 |
[Optic nerve damage caused by administration of ethambutol].
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Ethambutol; Female; Humans; Male; Middle Aged; Optic Nerve Diseases; Risk Factors | 1997 |
[Visual impairment due to optic neuropathy in 2 patients on amiodarone, and ethambutol and isoniazide therapy, respectively].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antitubercular Agents; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Optic Nerve Diseases; Optic Neuropathy, Ischemic; Vision, Low | 2001 |
Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutation.
Topics: Antitubercular Agents; Ethambutol; Humans; Male; Middle Aged; Mutation; Optic Atrophy, Hereditary, Leber; Optic Nerve Diseases; Tuberculosis, Pulmonary | 2001 |
Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment.
Topics: Adult; Ethambutol; Hemianopsia; Humans; Isoniazid; Kidney Transplantation; Male; Optic Nerve Diseases; Scotoma; Visual Fields | 1979 |
Histopathology of experimental ethambutol intoxication.
Topics: Animals; Axons; Ethambutol; Male; Optic Chiasm; Optic Nerve; Optic Nerve Diseases; Rats; Vacuoles | 1976 |
Toxic optic neuropathy and its experimental production.
Topics: Amblyopia; Cyanides; Demyelinating Diseases; Ethambutol; Humans; Optic Nerve Diseases; Smoking; Sulfur; Thiocyanates | 1976 |
The incidence of optic neuropathy in 84 patients treated with ethambutol.
Topics: Adolescent; Adult; Child; Color Perception; Ethambutol; Humans; Optic Nerve Diseases; Tuberculosis, Pulmonary; Visual Acuity; Visual Fields; Zinc | 1989 |
Pattern electroretinogram and visual evoked cortical potential in ethambutol optic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Cerebral Cortex; Electroretinography; Ethambutol; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Optic Nerve Diseases; Reaction Time; Visual Acuity | 1987 |
Use of contrast sensitivity measurement in the detection of subclinical ethambutol toxic optic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Ethambutol; Female; Humans; Male; Middle Aged; Optic Nerve Diseases; Pattern Recognition, Visual; Streptomycin; Tuberculosis, Pulmonary; Visual Acuity | 1987 |
[Color chart test for early detection and quantitative follow-up of the side effects of ethambutol on the optic nerve: the "65 Test"].
Topics: Adult; Color Perception Tests; Color Vision Defects; Ethambutol; Humans; Male; Optic Nerve Diseases; Risk | 1985 |